Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohortBritish journal of cancer, 2019-12, Vol.121 (12), p.991-1000 [Peer Reviewed Journal]Copyright Nature Publishing Group Dec 2019 ;The Author(s), under exclusive licence to Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0619-y ;PMID: 31719684Full text available |
|
2 |
Material Type: Article
|
The Genomic Landscape of Endocrine-Resistant Advanced Breast CancersCancer cell, 2018-09, Vol.34 (3), p.427-438.e6 [Peer Reviewed Journal]2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;ISSN: 1535-6108 ;EISSN: 1878-3686 ;DOI: 10.1016/j.ccell.2018.08.008 ;PMID: 30205045Full text available |
|
3 |
Material Type: Article
|
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research GroupJournal of clinical oncology, 2021-10, Vol.39 (28), p.3171-3181 [Peer Reviewed Journal]2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.00944 ;PMID: 34357781Full text available |
|
4 |
Material Type: Article
|
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast CancerJournal of clinical oncology, 2017-07, Vol.35 (19), p.2141-2148 [Peer Reviewed Journal]2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.70.8297 ;PMID: 28291390Full text available |
|
5 |
Material Type: Article
|
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trialThe lancet oncology, 2017-06, Vol.18 (6), p.743-754 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 1, 2017 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30313-3 ;PMID: 28526538Full text available |
|
6 |
Material Type: Article
|
Genomic Characterization of de novo Metastatic Breast CancerClinical cancer research, 2021-02, Vol.27 (4), p.1105-1118 [Peer Reviewed Journal]2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-1720 ;PMID: 33293374Full text available |
|
7 |
Material Type: Article
|
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trialThe lancet oncology, 2017-06, Vol.18 (6), p.732-742 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 1, 2017 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30312-1 ;PMID: 28526536Full text available |
|
8 |
Material Type: Article
|
Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant ChemotherapyAnnals of surgical oncology, 2018-09, Vol.25 (9), p.2596-2602 [Peer Reviewed Journal]Society of Surgical Oncology 2018 ;Annals of Surgical Oncology is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-018-6637-9 ;PMID: 29978369Full text available |
|
9 |
Material Type: Article
|
Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case SeriesThe oncologist (Dayton, Ohio), 2015-06, Vol.20 (6), p.586-592 [Peer Reviewed Journal]2015 AlphaMed Press ;AlphaMed Press. ;AlphaMed Press 2015 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2014-0243 ;PMID: 25948676Full text available |
|
10 |
Material Type: Article
|
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancerBreast cancer (Tokyo, Japan), 2024-05, Vol.31 (3), p.485-495 [Peer Reviewed Journal]The Author(s) 2024 ;ISSN: 1340-6868 ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-024-01560-yDigital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERsClinical cancer research, 2020-03, Vol.26 (5), p.1105-1113 [Peer Reviewed Journal]2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-19-2350 ;PMID: 31772121Full text available |
|
12 |
Material Type: Article
|
The prognostic significance of tumour―stroma ratio in oestrogen receptor-positive breast cancerBritish journal of cancer, 2014-04, Vol.110 (7), p.1744-1747 [Peer Reviewed Journal]2015 INIST-CNRS ;Copyright Nature Publishing Group Apr 1, 2014 ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2014.69 ;PMID: 24548861 ;CODEN: BJCAAIFull text available |
|
13 |
Material Type: Article
|
Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristicsPloS one, 2022-02, Vol.17 (2), p.e0264637-e0264637 [Peer Reviewed Journal]COPYRIGHT 2022 Public Library of Science ;2022 Nelson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Nelson et al 2022 Nelson et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0264637 ;PMID: 35213669Full text available |
|
14 |
Material Type: Article
|
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)Annals of oncology, 2019-05, Vol.30 (5), p.766-773 [Peer Reviewed Journal]2019 THE AUTHORS ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz061 ;PMID: 30796821Full text available |
|
15 |
Material Type: Article
|
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interfaceBritish journal of cancer, 2014-01, Vol.110 (2), p.535-545 [Peer Reviewed Journal]2015 INIST-CNRS ;Copyright Nature Publishing Group Jan 21, 2014 ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2013.730 ;PMID: 24346285 ;CODEN: BJCAAIFull text available |
|
16 |
Material Type: Article
|
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2 -Mutant Metastatic Breast CancerCancer discovery, 2020-02, Vol.10 (2), p.198-2132019 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.CD-19-0966 ;PMID: 31806627Full text available |
|
17 |
Material Type: Article
|
Comparison of the Diagnostic Accuracy of Magnetic Resonance Imaging with Sonography in the Prediction of Breast Cancer Tumor Size: A Concordance Analysis with Histopathologically Determined Tumor SizeAnnals of surgical oncology, 2015-11, Vol.22 (12), p.3816-3823 [Peer Reviewed Journal]Society of Surgical Oncology 2015 ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-015-4424-4 ;PMID: 25707494Full text available |
|
18 |
Material Type: Article
|
Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York CityBreast cancer research and treatment, 2020-07, Vol.182 (1), p.239-242 [Peer Reviewed Journal]Springer Science+Business Media, LLC, part of Springer Nature 2020 ;COPYRIGHT 2020 Springer ;Springer Science+Business Media, LLC, part of Springer Nature 2020. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-020-05667-6 ;PMID: 32405915Full text available |
|
19 |
Material Type: Article
|
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and StateJNCI : Journal of the National Cancer Institute, 2015-06, Vol.107 (6), p.djv048-djv048 [Peer Reviewed Journal]The Author 2015. Published by Oxford University Press. ;Copyright Oxford Publishing Limited(England) Jun 2015 ;The Author 2015. Published by Oxford University Press. 2015 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djv048 ;PMID: 25825511 ;CODEN: JNCIEQFull text available |
|
20 |
Material Type: Article
|
Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factorsBritish journal of cancer, 2017-01, Vol.116 (2), p.211-217 [Peer Reviewed Journal]Copyright Nature Publishing Group Jan 17, 2017 ;Copyright © 2017 The Author(s) 2017 The Author(s) ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2016.403 ;PMID: 27931045 ;CODEN: BJCAAIFull text available |